Indo US Bio-Tech Reports Strong Profit Growth and Record Net Sales in May 2025
Indo US Bio-Tech has announced its financial results for the quarter ending March 2025, showcasing a significant increase in Profit After Tax to Rs 8.73 crore, up 107.86% year-on-year. The company's net sales reached Rs 33.38 crore, reflecting a 54.9% growth compared to the previous four quarters.
Indo US Bio-Tech, a microcap company in the Other Agricultural Products industry, has recently reported its financial results for the quarter ending March 2025. The results, declared on May 26, 2025, indicate a notable shift in the company's evaluation, with the score rising to 19 from 14 over the past three months.The financial data reveals a significant growth in Profit After Tax (PAT), which reached Rs 8.73 crore, reflecting a year-on-year increase of 107.86%. This trend suggests a robust performance in profitability. Additionally, the company's net sales for the quarter amounted to Rs 33.38 crore, marking a growth of 54.9% compared to the average net sales of the previous four quarters, which stood at Rs 21.56 crore. This figure represents the highest net sales recorded by Indo US Bio-Tech in the last five quarters, indicating a strong near-term sales trend.
Overall, the financial results for Indo US Bio-Tech highlight positive developments in both profitability and sales performance, contributing to the recent adjustments in its evaluation.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
